Christine and Tate Ezzi, of Sherwood, Ark., thought-about vaccination, however heard a false rumor that the shot might trigger miscarriage. She was pregnant with their sixth youngster and determined to attend. He did, too. Each got here down with covid, nevertheless it was worse for her, then 23 weeks pregnant. She had “every part, each symptom you’ll be able to consider,” her husband mentioned.
Two years into the pandemic, we’ve gotten so much higher at tackling the coronavirus on the extremes of an infection. Now we have preventives—together with masks, distancing, air flow, and our MVP vaccines—that may be deployed upfront of a viral encounter. Now we have regimens of final resort: medication, equivalent to dexamethasone, that do their finest, lifesaving work in hospitals with educated health-care employees, in sufferers whose illness has already turned extreme. However within the chasm that sits in between—the hazy interval after an infection and earlier than extreme sickness—respectable instruments that may derail COVID’s development have been sparse.
We now have a brand new candidate aiming to fill that essential area of interest: the experimental antiviral molnupiravir, developed by Merck and Ridgeback, which is available in an easy-to-swallow tablet. In response to an organization press launch posted this previous Friday, the drug can halve charges of hospitalization amongst individuals